Dr. Ross is a Buffalo Spree Top Doctor! See all of our physicians who made this year's list.
Top Doctors 2023
Cancers Treated:
Specializing In:
Leukemia, Adult Multiple Myeloma LymphomaResearch Interests:
Bone marrow transplantation Hematological malignancies Clinical Trials in Stem Cell Transplantation and/or Hematologic MalignanciesAbout Maureen Ross
Positions
Roswell Park Comprehensive Cancer Center
- Professor of Oncology
- Interim Chief, Transplant and Cellular Therapy Program
- Department of Medicine
Background
Education and Training:
- University of Miami, Miller School of Medicine, Miami, FL
- PhD - Stanford University, Palo Alto, CA
Residency:
- Duke University Medical Center, Durham, NC
Fellowship:
- Duke University Medical Center, Durham, NC
Board Certification:
- American Board of Internal Medicine
- American Board of Medical Oncology
Professional Memberships:
- American Society of Hematology
- American Society for Blood and Marrow Transplantation
- American Society of Clinical Oncology
- 1990-1995 - Cancer and Leukemia Group B
- 2010-Present - Cancer and Leukemia Group B
Clinical Trials
Expanded Access Program (EAP) for Ciltacabtagene Autoleucel (Cilta-Cel) Out-of-Specification (OOS) in Participants With Multiple Myeloma
Learn More
A Study Evaluating Safety and Efficacy of Venetoclax in Combination With Azacitidine Versus Standard of Care After Allogeneic Stem Cell Transplantation (SCT) in Participants With Acute Myeloid Leukemia (AML)
Learn More
Featured on Cancer Talk
Publications
- Badari A; Brown, Karen S; Paplham, Pamela D; Syta, Margaret M; Burgess, Michele L; Arnold, Karen N; Liu, JoAnn J; Chen, George L; Liu, Hong; Ross, M.; Hahn, Theresa E; McCarthy, Philip L Managing cardiac amyloidosis: Auto or allotransplant? American journal of hematology 86 (10), 885-886 , 2011
- Jitawatanarat P, Desai A, Sharda P, Liu H, Ross, M, Hernandez- Llizaliturri F J, McCarthy PL, Chen GL, . Progressive Chronic lymphocytic leukemia after allogeneic hematopoietic cell Transplantation. J. Natl. Compr. Cancer Network 2012 Oct 1;10(10):1203-6.
- Chen G, Liu, H, Zhang, Y, Thomas, J, Ross, M, Wang, E, Block, A, Sait, S, Deeb, G, Wallace, P, Wetzler, M, Hahn, T, McCarthy, P. Early versus late preemptive allogeneic hematopoietic cell Transplantation for relapsed or refractory acute myeloid leukemia. Biol Blood Marrow Transplant 2014 Sep;20(9); 1369-74: doi: 10.1016/j.bbmt.2014.05.013. Epub 2014 May 24.
- Chen, G., Zhang, Yall, Hahn, T.E, Abrams, Scott I, Ross, M., Liu, H., McCarthy, P. L. Acute GVHD Prophylaxis, with standard-dose, micro-dose, or no MTX after fludarabine/melphalan Conditioning. Bone Marrow Trans. 2014(49)suppl.2;248-253.
- Sivaraj D; Green MM; Cifci AM; Zahid MF; Johns AA; Ross, Maureen; Gasparetto C. Can We Cure Light Chain Deposition Disease of the Kidneys? A Review and Case Report Of a Patient Treated With a Triple Transplant Approach. Clinical Lymphoma Myeloma And Leukemia. 2016 (16) 6; e95-e100.